Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.

Sho IketaniFarhad ForouharHengrui LiuSeo Jung HongFang-Yu Lin Manoj S NairArie ZaskYaoxing Huang Li Xing Brent R Stockwell Alejandro Chavez David D Ho

Published in: Nature communications (2021)

Keyphrases

sars cov

respiratory syndrome coronavirus